Paydirt
CR
Insider

Chad M Robins

CEO and Chairman

Chad M Robins (CEO and Chairman) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $14.8M of ADPT (597,271 sh across 2 lots, as filed), executed Aug 17.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$39.6M
shares × price, as filed
Last traded
Aug 18
Filed Aug 19

Median ADV $72.7M across their filed names

Open performance
Volume by month
$14.8M$7.4M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · sells $6.4MMar 2025 · sells $1.6MNov 2025 · sells $1.3MDec 2025 · sells $3.1MJan 2026 · sells $1.9MFeb 2026 · sells $2.3MMar 2026 · sells $14.5MApr 2026 · sells $1.8MAug 2026 · sells $14.8M
Buys $0 Sells $47.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names
ADPT Adaptive Biotechnologies Corporation ADPT · 0 buys · 11 sells 11 filings
Recent filings
ADPTSALE Adaptive Biotechnologies Corporation View filing → $1.6M
219,569 sh across 3 lots
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET
ADPTSALE Adaptive Biotechnologies Corporation View filing → $2.4M
285,187 sh across 2 lots
Exec Feb 19 2025
Filed Feb 21 2025 · 5:30 PM ET
ADPTSALE Adaptive Biotechnologies Corporation View filing → $4.0M
470,368 sh across 3 lots
Exec Feb 13 2025
Filed Feb 18 2025 · 5:30 PM ET